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Summary Aminolaevulinic acid (ALA) is the first committed step in haem synthesis. In the presence of excess
ALA the natural regulatory feedback system is disrupted allowing accumulation of protoporphyrin IX (PP IX)
the last intermediate product before haem, and an effective sensitiser. This method of endogenous photosen-
sitisation of cells has been exploited for photodynamic therapy (PDT). We have studied the fluorescence
distribution and biological effect of induced PP IX in normal and tumour tissue in the rat colon. Fluorescence
in normal colonic tissue was at a peak of 4 h with a rapid fall off by 6 h. The fluorescence had returned to
background levels by 24 h. All normal tissue layers followed the same fluorescence profile but the mucosa
showed fluorescent levels six times higher than the submucosa, with muscle barely above background values.
At 6 h the ratio of fluorescence levels between normal mucosa and viable tumour was approximately 1:6. At
this time laser treatment showed necrosis ofnormal mucosa and tumour with sparing of normal muscle. There
was good correlation between the fluorescence distribution and the biological effect ofALA-induced photosen-
sitisation on exposure to red light. ALA may be superior to conventional sensitisers for tumours that produce
haem as the PP IX is synthesised in malignant cells while the other sensitisers mainly localise to the vascular
stroma of tumours. There is also a greater concentration difference between the PP IX levels in tumours and in
normal mucosa and normal muscle than with the other photosensitisers raising the possibility of more selective
necrosis in tumours.
Photodynamic therapy (PDT) is concerned with the use of
light to activate a photosensitising drug which results in the
generation of cytotoxic species. Much work has been under-
taken in this field with the same major problems becoming
apparent. Although PDT has been based on the selective
retention of photosensitising drugs by tumours this is clearly
not the case with a maximal ratio of 3:1 tumour to normal
tissue with the commonly used photosensitisers (Tralau et al.,
1987). At 48 h after an intravenous injection of aluminium
sulphonated phthalocyanine (AlSPc) colonic tumours con-
tained approximately twice as much sensitiser as normal
colon. Fluorescence microscopy studies were performed on
the same specimens showing significant photosensitiser
accumulation in tumour stroma whereas tumour cells and
normal mucosa contained similar amounts. Therefore selec-
tivity between normal and tumour tissue is minimal and
following exposure to red light considerable normal tissue
damage is experienced where tumour tissue invades normal
tissue (Barr et al., 1991). New strategies are required to
enhance PDT selectivity. Sensitiser photodegradation may be
exploited to improve selectivity as demonstrated by Barr et
al. (1990), who used low dose sensitisation with AlSPc in the
colonic tumour model, although with this method the extent
of tumour necrosis was considerably reduced. A further
problem experienced with the best known clinical photosen-
sitiser haematoporphyrin derivative (HpD) is the extended
skin photosensitivity which may persist for months (Zalar et
al., 1977).
Skin photosensitivity and other side effects of porphyrin
sensitisation are experienced by patients suffering from
hepatic porphyria, with worsening health after treatment with
barbiturates. These observations led to the discovery that
administration of certain drugs and chemicals into a normal
animal produced symptoms which mimicked those of hepatic
porphyria and the condition is known as chemical porphyria.
This work has been the subject of several review articles
(Drabkin, 1963 and Granick, 1965). Chemical porphyria,
although generally used as an experimental model for unders-
tanding the porphyria disease states, has now been suggested
as a novel means of endogenous sensitisation for PDT
(Divaris et al., 1990). This approach involves the administra-
tion of 5-aminolaevulinic acid (ALA) which results in
endogenous photosensitisation both in cultured cells (Malik
& Djaldetti, 1979) and in whole animals (Sima et al., 1981).
ALA is present naturally in mammalian cells since it is the
first committed intermediate in the haem biosynthesis path-
way. Through the introduction of an excess of ALA either in
vitro, or in vivo, the regulatory feedback system is overloaded
causing an accumulation of porphyrin precursors to haem,
particularly protoporphyrin IX (PP IX), an active in vitro
photosensitiser. Divaris et al. (1990) have performed in vivo
studies which showed that after intraperitoneal administration
of ALA to mice PP IX accumulated in the skin in sufficient
amounts to cause photosensitised damage on exposure to
light. This group has also shown that the urothelium of the
bladder and the endometrium in the uterus become highly
sensitised following intraperitoneal administration of ALA,
whereas the underlying layers in these organs exhibited
relatively little sensitisation which could enable selective dest-
ruction of superficial cancers in the urothelium and endomet-
rium without causing perforation to the bladder or uterus.
Some promising results have recently been obtained in a
clinical trial after topically applied ALA, which achieved a
90% complete response rate in the treatment of basal cell
carcinomas (Kennedy et al., 1990). It should be noted that
direct administration of PP IX itself has been limited by the
poor water solubility of this particular porphyrin.
The experimental studies presented in this paper have been
undertaken on another hollow organ, the colon, using intra-
venous administration of ALA. The aim was to investigate
and quantify the phorphyrin fluorescence in rat colonic
tissue, both normal and tumour, and to determine micro-
scopically which sites exhibited porphyrin accumulation as a
function of dose and time after administration. These tissues
were then treated with laser light for assessment of photosen-
sitising activity and selectivity of damage. A comparison was
made between the fluorescence distribution and the biological
effect of ALA-induced photosensitisation.
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Materials and methods
5-ALA was obtained from Sigma Chemical Company (UK),
with a purity of 98%, dissolved in phosphate buffered saline
at a concentration of 80 mgml-' and used within 24 h. ALA
was administered intravenously in doses of up to 200 mg
kg-' via tail vein injection to Wistar rats (weighing
125-200 g) under general anaesthetic from intramuscular
Hypnorm (Fentanyl and fluanisone, Jansen Pharmaceuticals
Ltd.). Colonic tumours were chemically induced in male
Wistar rats using dimethylhydrazine (DMH) (Aldrich
Chemical Company, UK) as reported by Filipe (1975).
colon immediately removed. Strips of colon were-opened,
cleaned and mounted flat on glass slides with the mucosal
surface uppermost. The slides were placed in a fluorimeter
(Perkin-Elmer LS 5B) at a 30 degree angle to the excitation
beam in order to minimise scattered light which was further
attenuated by a longpass filter (OG550, Schott) mounted on
the emission port. The emission spectra (uncorrected) of each
sample was then recorded using an excitation wavelength of
514nm which enabled examination of the complete band of
fluorescence extending from approximately 600-700 nm.
Control strips were also examined to enable quantification
and exclusion of autofluorescence and scattered light from
unsensitised colon.
Fluorescence microscopy studies
Imaging and quantification of fluorescence in sections of
normal and tumour tissue were achieved using fluorescence
microscopy. At 5 and 30 min and 1, 2, 3, 4, 5, 6, 8, 17 and
24 h following administration of ALA the animals were
killed and normal, or tumour, tissue removed from the colon
and immediately frozen in isopentane (BDH Ltd., UK)
cooled in liquid nitrogen. Frozen sections of 10 ltm thickness
were cut (Cryostat E microtome, Reichert Ltd.) and stored at
- 70°C. Tissue sections were prepared and imaged with a
minimum of light exposure to avoid bleaching of porphyrin.
The fluorescence microscope (Olympus IMT-2) was
attached to a charged-coupled device (CCD) camera system
(Wright Instruments Ltd., model 1). This photometric imag-
ing system is highly sensitive with comparable detection
efficiency to photomultipliers and has been fully described in
previous studies on AISPc fluorescence imaging, Chan et al.
(1989), Chatlani et al. (1991), Barr et al. (1988). Fluorescence
was excited using an 8 mW helium neon laser operating at
632.8 nm, with the output directed through a liquid light-
guide (via a 10 nm bandpass filter to remove extraneous
light) onto a dichroic mirror in the epi-fluorescence micro-
scope which incorporated phase-contrast attachments. Imag-
ing of porphyrin fluorescence has, in contrast to this work,
usually employed excitation near 400 nm corresponding to
the intense Soret band absorption. However, excitation at
these shorter wavelengths gives rise to considerable back-
ground luminescence from the microscope optics and much
higher tissue autofluorescence and therefore offers no clear-
cut advantage to the excitation wavelength employed here
which, moreover, is very close to the selected therapeutic
wavelength of 630 nm. Fluorescence was detected in the
range 660 to 710 nm, using a combination of bandpass
(Omega Optical Inc.) and longpass (Schott RG655) filters.
The CCD sensor (578 x 385 pixels, model P8603, EEV Ltd.)
was cryogenically cooled, and imaging operations and pro-
cessing were controlled by an IBM AT/PC clone. Both false
colour coded or black and white images were generated by
the computer.
Fluorescence was quantified digitally (software provided by
Wright Instruments Ltd.) using box superimposition on the
image to give an average number of counts per pixel. Specific
tissue layers and/or whole images were analysed using this
technique to determine the relative intensities of porphyrin
fluorescence, after making small corrections for autofluo-
rescence, luminescence from the epi-fluorescence optics, and a
computer generated off-set. After fluorescence imaging, the
sections were fixed and stained with haematoxylin and Van
Gieson's (HVG) stains and the same microscopic areas were
then photographed for confirmation of histology.
Fluorescence spectroscopy
Fluorescence emission spectra were observed ex vivo from
normal rat colon strips showing ALA-induced sensitisation.
Porphyrins exhibit characteristic fluorescence profiles and this
provides a means of confirming the presence of (and possibly
distinguishing) the porphyrin species synthesised at a given
time after introduction of ALA. Normal rats were given a
200 mg kg-' dose of ALA and killed at times corresponding
to those for the fluorescence microscopy studies and their
Phototherapy studies
The effect of light on normal and tumour tissue after i.v.
administration of 200 mgkg' ALA was studied. The light
source used was a copper vapour pumped dye laser (Oxford
lasers Ltd.) which was set to deliver 50 J (100 mW for 500 s)
from a 200gm fibre at a wavelength of 630 nm which corres-
ponds to a porphyrin absorption band. Laser treatments
were performed at laparotomy with the fibre just touching
the normal colonic mucosa, or inserted into the apex of the
tumour at a depth of 1 mm. Normal colonic tissue was
treated at 5, 20, 30 and 40 min and 1, 2, 3, 4, 5, 6 and 24 h,
and tumour was treated at 6 h. Control animals that had not
been given ALA were treated as before to quantify any
thermal damage. All animals were killed 72 h later when
mucosal damage, when present, was at a maximum (Barr et
al., 1987). To assess necrosis macroscopically at any treated
laser site both the greatest and the smallest diameter of
damage were recorded and the mean diameter calculated.
Presence of necrosis was confirmed microscopically.
Results
Fluorescence microscopy andphotometry
Initial measurements of ALA-induced fluorescence using the
CCD imaging system were made on normal colonic tissue
sections taken at 3, 6 or 24 h as a function of ALA dose: 50,
100, 150 or 200 mg kg-' respectively. For these times greatest
fluorescence was found at 3 h with background levels being
reached by 24 h. After the 200 mg kg-' dose there was still
significant sensitisation at 6 h and this dose was therefore
considered to be the most useful therapeutically as it pro-
vided a longer range of times available for PDT treatment.
Sections of normal colon were examined over a greater range
of time points (5 and 30 min, 1, 2, 3, 4, 5, 6, 8, 17 and 24 h,
post-administration with 200 mg kg-', and the fluorescence
levels in the mucosa, submucosa and muscle layers were
determined separately. The results are shown in Figure 1. At
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Figure 1 Microscopic fluorescence levels in tissue layers of the
normal colon as a function of time after administration of ALA.
-0 - muscle, -* - mucosa, -U - submucosa.820 J. BEDWELL et al.
30 min, relatively low fluorescence was observed in the
mucosa, with no discernible fluorescence in submucosa and
muscle. Fluorescence levels increased rapidly reaching a max-
imum in all layers at 4 h, thereafter returning to background
levels at 17 h. All layers showed comparable fluorescence
profiles vs time although fluorescence levels varied con-
siderably according to the tissue site. At all times the mucosa
exhibited the highest fluorescence, approximately six times
greater than submucosal fluorescence, with muscle barely
above background levels.
Figure 2 shows the fluorescence images of normal (a) and
tumour tissue (c) 6 h after introduction of 200 mg kg-' ALA
together with the subsequent photographs of the same sec-
tions stained with an HVG stain ((b) and (d)). There is
specific sensitisation of tumour cells with tumour stroma
exhibiting a three times lower average fluorescence level. At
this time (6 h post-administration) we estimate that the
tumour glands gave on average a fluorescence ratio of
approximately 6:1 to normal mucosal glands, 30:1 to normal
submucosa and 60:1 to normal muscle. Confirmation of the
b
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Figure 2 Fluorescence images of nornal a, and tumour tissue c, 6 h after introduction of 200 mgkg-' ALA together with the
subsequent photographs of the same sections stained with an HVG stain (b, normal mucosa (M), muscle (MU) and submucosa (S)
and d, tumour stroma (TS) and tumour gland (TG)). Scale: white bar represents 80gm. The false colour code begins at 40 counts
to allow for background fluorescence.
specificity of sensitisation of tumour cells was obtained by
re-imaging Figure 2c using a higher power and is depicted in
Figures 3a and b, which also show that sensitisation is
restricted to extra-nuclear sites. At all times studied, blood
vessels exhibited low fluorescence levels and this is shown in
Figure 4a and b. This figure is of images from normal colon
4 h post-administration demonstrating that blood vessel sen-
sitisation is comparable to that of the surrounding connective
tissue, in contrast to the intense mucosal fluorescence.
Fluorescence spectroscopy
The fluorescence emission spectra from normal rat colon
strips (excitation wavelength 514nm) 30min and 6 h after
ALA-induced sensitisation and unsensitised control colon are
shown in Figure 5. The spectra from the sensitised colons
differ in intensity of fluorescence but appear to exhibit the
same spectral profile with maxima at approximately 636 and
704 nm; both spectra are considerably more intense than the822 J. BEDWELL et al.
U1)
C-
Figure 3 High power image of Figure 2c shown in a with
subsequent stained section b. Arrows in b indicate two typical
tumour nuclei depicting non-fluorescence of these structures.
Scale: white bar represents 20 Im.
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Figure 5 Fluorescence emission spectra (excitation wavelength
514 nm) from normal colon strips 6 h and 30 min
after 200 mg kg-' ALA, and unsensitised control tissue
control spectrum which apart from scattered light may also
contain a contribution from endogenous porphyrin species.
Further spectra were recorded at 1 and 2 h which gave the
same maxima, and excitation spectra recorded from 500-
650nm with detection set at 700 nm were also consistent with
PP IX (data not shown). The results are essentially identical
to the in vivo spectra obtained by Pottier et al. (1986) from
skins of mice injected i.p. with ALA, who assigned the
spectrum solely to protoporphyrin IX. The apparent small
red-shift compared to the spectrum in dimethyl sulphoxide
solution (maximum at 629 nm) was ascribed to binding with
protein substrates as PP IX bound to human serum albumin
shows a fluorescence maximum at 635 nm (Lamola et al.,
1981).
Phototherapy studies
The mean diameter of necrosis in normal colonic mucosa was
measured as a function of time after administration of ALA
and results are shown in Figure 6. These results show broad
correlation with the corresponding mucosal fluorescence
measurements from the CCD imaging studies with greatest
damage also found at 4 h (mean diameter 9.1 ± 1.5 mm) with
no visible necrosis at 24 h. The notable exception was at
30 min where considerable necrosis was seen (mean diameter
7.2 ± 1.0 mm) even though mucosal fluorescence was more
than an order of magnitude lower than at 4 h.
Histological examination was undertaken on all specimens
showing macroscopic necrosis 72 h after laser treatment. At
all treatment times after introduction of ALA, an acute
inflammatory infiltrate, mainly comprising of monocytes and
polymorphonuclear neutrocytes, was seen throughout all tis-
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Figure 4 Fluorescence image of normal colon a, 4 h after intro-
duction of 200 mg kg- ' ALA together with the subsequent
stained section b. Arrows in b indicate blood vessels. Scale: white
bar represents 80 tim.
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Figure 6 Diameter of necrosis in normal colonic mucosa
measured as a function of time after administration of ALA.
Each point represents the mean ( ± 1s.d.) of five animals.ALA-INDUCED PP IX IN THE RAT COLON 823
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sue layers of the colon but there was little evidence o.
muscular layer necrosis in the specimens examined. Thi:
relative sparing of the muscle layer of normal colon is showt
in Figure 7a treated at 6 h, with the corresponding higl
power image b. Tumour tissue treated at the same tim(
shows obvious necrosis (Figure 8).
Discussion
A new means of sensitisation for PDT has been studies
which involves the introduction of 5-aminolaevulinic aci(
(ALA) to induce endogenous porphyrin sensitisation. W(
have investigated the microscopic distribution and spectro,
scopy of ALA-induced porphyrin fluorescence at variou,.
time intervals after the introduction of ALA, in both norma
and tumour tissue in the rat colon. It has been shown tha-
the fluorescence spectrum in normal colon is consistent witl
that of protoporphyrin IX and using quantitive fluorescenc(
microscopy that the fluorescence is mainly localised in th(
normal mucosa, with approximately six times less fluor.
escence in submucosal tissue and with muscle barely exceed,
ing background fluorescence levels. We have found that al
6 h there is a considerable differential between porphyrir
fluorescence in tumour and normal colon. At this time color
tumour cells exhibit specific fluorescence with average level-.
h Figure 8 Histological section of colonic tumour treated 6 h after
,e 200 mg kg- ALA showing necrotic tumour (NT) and viable
ie tumour (VT) beyond the treatment site. Scale: white bar
r-represents 200 tLm.
tt
n
n that are approximately six times higher than normal mucosa,
Is 30 times higher than normal submucosa, and 60 times higher
than normal muscle levels. Our fluorescence spectroscopic
and pharmacokinetic data are consistent with previous work
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sitisation by PP IX occurs rapidly reaching a maximum near
3 h in the skin and declining to background levels by 24 h.
The assumption that localisation and intensity of micro-
scopic fluorescence correlates with PDT induced damage has
generally been confirmed with our phototherapy studies. The
mean diameter of necrosis in normal colon (allowing for the
geometry of the light delivery) correlated with the relative
porphyrin fluorescence levels between S min and 24 h, except
at 30 min (discussed below). Additionally, necrosis in all
specimens has been restricted to the colonic mucosa with
muscle remaining viable. Divaris et al. (1990) have shown
previously that after systemic administration of ALA to mice
the intensity of the ALA-induced PP IX fluorescence in skin
also correlated with the amount ofphototoxic damage. With
phototherapy it has proved possible to kill tumour tissue
with ALA-induced sensitisation. Laser irradiation at 630 nm
of DMH-induced colonic tumour has shown tumour cell kill
at 6 h post-administration when necrotic damage to normal
colon is limited to mucosa (which is capable of healing
through regeneration - Barr et al., 1987). It is reassuring
that necrosis does not extend into the muscle layer, although
there is evidence of an inflammatory infiltrate. Previous work
has shown that the mechanical integrity of the colon can be
maintained even if there is muscle necrosis, probably due to a
lack of any deleterious effect on the submucosal collagen
(Barr et al., 1987), although experiments on bladder show
that even if there is histological evidence ofmuscle healing by
regeneration, the muscle function may be permanently
damaged (Pope & Bown, 1991) and so clearly it is better that
there is no muscle damage. Tumours were only examined and
treated 6 h after administration of ALA, and in due course
experiments should be carried out to look at other time
intervals, but this time does show considerable potential for
selective tumour treatment. We have also demonstrated a
significant advantage of ALA-induced porphyrin over con-
ventional sensitisers in that the level of sensitisation returns
to background values in both normal and tumour tissue by
24h. This suggests that continued tissue sensitisation post-
treatment will not be a problem.
An unexpected result was found when treating normal
tissue 30min after introduction of ALA. A relatively low
fluorescence reading was obtained in the mucosa at this time
with no discernible fluorescence in the submucosa and muscle
layers, so we would have predicted little, if any, damage after
light treatment. However, significant photodamage was
found with a diameter of necrosis of 7.2 ± 1.0 mm, which
b
Figure 7 Histological section of normal colon treated 6 h after
200 mg kg-' ALA showing necrotic mucosa (NM), inflammatory
infiltrate in the submucosa (S) and relative sparing of the muscle
layer (MU). Scale: white bar represents 200lim in a and 80jum in
b.824 J. BEDWELL et al.
could be observed histologically as comprising necrotic
mucosa and a particularly heavy inflammatory infiltrate in
the submucosa and muscle layers. The mechanism of
photodamage in Friend erythroleukaemic cells from the use
of ALA has been shown to be a combination of the cellular
location and the chemical nature of the photosensitiser at a
particular time (Malik & Lugaci, 1987). They have reported
that endogenous porphyrins initially accumulated in the
mitochondria and then translocated to other photosensitive
sites within these cells. A possible explanation of our
anomalous. in vivo results would be that 30min after ALA
administration the induced porphyrin (in this case PP IX) is
located at particularly photosensitive sites, such as the
mitochondria, and that thereafter the porphyrin is located in
other less photosensitive sites in the cell. Another explanation
is that other photoactive porphyrins (e.g. uroporphyrin) were
present at the shorter times, but given the consistency of the
fluorescence spectra recorded from 30 min to 6 h we believe
this to be unlikely, although we can offer no explanation for
the specific production of PP IX in vivo which is contrary to
the in vitro results. Chromatographic analysis of the por-
phyrin content may provide more definitive conclusions.
Interesting comparisons can be made with our recent
studies of AlSPc sensitisation of normal rat colon (Chatlani
et al., 1991), which showed that AlSPc fluorescence was
particularly high in and adjacent to blood vessel walls, in
complete contrast to the results presented here. The
mechanism of photodamage may therefore differ profoundly
between these two methods of sensitisation. ALA-induced
sensitisation would appear to rely on direct cell kill whereas
the mechanism with AlSPc relies primarily on vascular
effects. This conclusion may have the most far reaching
implications for ALA. With the current photosensitisers
which localise mainly to the vascular stroma of tumours and
normal areas, it is only possible to destroy small numbers of
tumour cells infiltrating normal areas by also necrosing the
normal tissue (Barr et al., 1991). In contrast, the combination
of tumour to normal selectivity and synthesis of PP IX in
individual malignant cells may make it possible to kill
infiltrating cells without so much damage to normal struc-
tures. Naturally, this is only applicable to tumours than can
synthesise PP IX from ALA, but could be extremely valuable
for sterilising the resection margins after tumour surgery.
Since PDT after ALA has shown a high degree of selectivity
of necrosis to the normal colonic mucosa, this treatment
could have a particular application for intramucosal car-
cinomas of hollow organs, and also potentially an applica-
tion in peritoneal endometriosis.
In summary, this new method of sensitisation has several
advantages over conventional exogenous photosensitiser
administration. Sensitisation is rapid with near maximal tis-
sue levels of PP IX being reached at 3-4 h. Photosensitisa-
tion of tissues including skin (Pottier et al., 1986) is likely to
be comparable in intensity to that after HpD, but would only
be expected to last 24 h instead ofseveral weeks. The absorp-
tion peak of PP IX in the red part of the spectrum is low
(comparable to that for HpD, and much lower than that for
AlSPc), but this just means that more light is required. The
real bonus is the direct sensitisation of individual malignant
cells, and if this can be exploited, the potential for the
technique is very considerable.
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